For those that follow the Covid post on the football board, I have previously advised about Cytodyn Inc. CYDY, a little small biotech firm out of Vancouver , Washington , who has a a drug called Leronlimab that will likely be the next treatment for Covid in less than a month. Yesterday it finished it’s mild/ moderate trial and on Monday , the severe/ critical trial will be able to reveal interim results. After the data is collected it will be given to the FDA in the next week to 10 days and I predict approval for Covid in July. Leronlimab initially has proved safe in over 800 patients in Phase 3 trials for AIDS and was on course to be approved as a mono therapy AIDS drug. It also is in Phase 2 trials for triple breast cancer and recently for NASH ( liver disease and fibrosis). It also might have another 10 indications for Ms,, Pancreatic and prostrate cancer, etc. it will have 10 phase 2 trials for different indications before the end of the year .
The company is presently on the OTC BUT up listing to the NYSE is happening within the next 2-3 weeks. The stock was .50 for years until end of February when it ran up to 2.50. It is presently on a 6 day surge and trading at about $7.00 as I type this as it is breaking records on stock price and volume , which was like a million , was 18.5 million yesterday , and already almost 7 million today. The anticipation from the early EIND use, which had really favorable results have ramped up in anticipation of the great trial results forthcoming . Leronlimab blocks the cytokines storm, reduces the viral load, and brings the immune system to homeostasis allowing it to fight normally , doing all 3 things. It will save lives and allow us to have a somewhat normal life. Good luck to all.